Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 5 clinical trials for: Urothelial,Bladder cancer, 150 miles

2 trials recruiting
Be6A Clinical Trials
Evaluating sigvotatug vedotin to see if it will extend life expectancy and increase the period before cancer recurs.
  • Bladder Cancer
  • Recruiting
Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
  • Bladder Cancer
  • Recruiting
NCT07090499
Sex: All
Age: 18+
Locations: 2
View study
Recruiting
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
  • Bladder Cancer
  • Recruiting
NCT05911295
Sex: All
Age: 18+
Locations: 332
View study
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
  • Bladder Cancer
  • Recruiting
NCT04389632
Sex: All
Age: 18+
Locations: 133
View study
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
  • Bladder Cancer
  • Recruiting
NCT04879329
Sex: All
Age: 18+
Locations: 183
View study
Oct 20, 2025 - Planned start date (Not yet recruiting)
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
  • Bladder Cancer
  • Not yet recruiting
NCT07206225
Sex: All
Age: 18+
Locations: 35
View study